HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shiro Akinaga Selected Research

CCR4 Receptors

6/2015Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.
4/2014Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma.
3/2014Reactivation of hepatitis B virus in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab.
9/2012Targeting chemokine receptor CCR4 in adult T-cell leukemia-lymphoma and other T-cell lymphomas.
3/2012Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study.
11/2004The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shiro Akinaga Research Topics

Disease

27Neoplasms (Cancer)
04/2016 - 10/2002
9Breast Neoplasms (Breast Cancer)
01/2018 - 06/2003
7Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
03/2014 - 11/2004
3Exanthema (Rash)
01/2018 - 08/2013
3Carcinoma (Carcinomatosis)
04/2016 - 06/2003
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
04/2014 - 03/2010
2Hyperglycemia
01/2018 - 04/2016
2Neutropenia
07/2014 - 04/2014
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
04/2014 - 09/2012
2T-Cell Lymphoma (Lymphoma, T Cell)
04/2014 - 09/2012
2Leukemia
08/2009 - 08/2007
2Prostatic Neoplasms (Prostate Cancer)
05/2008 - 07/2003
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016
1Lymphoma (Lymphomas)
06/2015
1Ovarian Neoplasms (Ovarian Cancer)
08/2014
1Febrile Neutropenia
07/2014
1Anemia
04/2014
1Stomach Neoplasms (Stomach Cancer)
04/2014
1Hepatocellular Carcinoma (Hepatoma)
04/2014
1Infections
03/2014
1Diarrhea
08/2013
1Renal Cell Carcinoma (Grawitz Tumor)
08/2013
1Proteinuria
08/2013
1Hypertension (High Blood Pressure)
08/2013
1Dysphonia (Spastic Dysphonia)
08/2013
1Stevens-Johnson Syndrome (Lyell's Syndrome)
05/2013
1Neoplasm Metastasis (Metastasis)
12/2011
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2011
1Multiple Myeloma
05/2010
1Genetic Translocation (Chromosomal Translocation)
05/2010
1Chromosome Aberrations (Chromosome Abnormalities)
05/2010

Drug/Important Bio-Agent (IBA)

8mogamulizumabIBA
06/2015 - 03/2010
7Monoclonal AntibodiesIBA
03/2014 - 11/2004
6CCR4 ReceptorsIBA
06/2015 - 11/2004
6Steryl-Sulfatase (Steroid Sulfatase)IBA
02/2009 - 06/2003
5Proteins (Proteins, Gene)FDA Link
01/2013 - 10/2003
5Estrogens (Estrogen)FDA Link
02/2009 - 06/2003
4Hormones (Hormone)IBA
01/2018 - 08/2007
4EnzymesIBA
02/2009 - 06/2003
4Messenger RNA (mRNA)IBA
02/2009 - 06/2003
3Aromatase (CYP19)IBA
01/2018 - 09/2003
3Pharmaceutical PreparationsIBA
04/2014 - 08/2007
3estrone sulfotransferaseIBA
02/2009 - 06/2003
3Telomerase (Telomerase Reverse Transcriptase)IBA
02/2006 - 05/2003
2Letrozole (Femara)FDA LinkGeneric
01/2018 - 04/2016
2Lapatinib (GW572016)FDA Link
01/2018 - 04/2016
2KW-2450IBA
01/2018 - 04/2016
2ErbB Receptors (EGF Receptor)IBA
04/2016 - 01/2016
2ARQ 197IBA
01/2016 - 04/2014
2Biomarkers (Surrogate Marker)IBA
11/2015 - 04/2014
2litronesibIBA
11/2015 - 07/2014
2Adenosine Triphosphate (ATP)IBA
04/2014 - 01/2013
2monorden (radicicol)IBA
01/2013 - 10/2003
2Phosphotransferases (Kinase)IBA
01/2013 - 08/2009
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2013 - 05/2010
2KW-2478IBA
01/2013 - 05/2010
2Humanized Monoclonal AntibodiesIBA
12/2011 - 05/2008
2Biological ProductsIBA
05/2010 - 06/2003
2AndrogensIBA
05/2008 - 05/2005
2KW 2581IBA
12/2007 - 08/2007
2EstroneFDA Link
08/2007 - 09/2003
2GRN163IBA
07/2003 - 05/2003
1human ERBB2 proteinIBA
01/2018
1Drug CombinationsIBA
01/2018
1afimoxifene (hydroxytamoxifen)IBA
01/2018
1Insulin-Like PeptidesIBA
04/2016
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2016
1Tyrosine Kinase InhibitorsIBA
01/2016
1Gefitinib (Iressa)FDA Link
01/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2014
1tivozanibIBA
08/2013
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
08/2013
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2013
1Molecular Chaperones (Chaperone, Molecular)IBA
01/2013
1geldanamycinIBA
01/2013
1Chemokine ReceptorsIBA
09/2012
1G(M2) Ganglioside (Ganglioside GM2)IBA
12/2011
1BIW-8962IBA
12/2011
1AntibodiesIBA
12/2011
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
05/2010
1Green Fluorescent ProteinsIBA
05/2010
1Aurora KinasesIBA
08/2009
1Imatinib Mesylate (Gleevec)FDA Link
08/2009
1KW 2449IBA
08/2009
1Histones (Histone)IBA
08/2009
1Paclitaxel (Taxol)FDA LinkGeneric
05/2009
1Antineoplastic Agents (Antineoplastics)IBA
05/2009
1KinesinsIBA
05/2009
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
05/2008
1Complementary DNA (cDNA)IBA
05/2008
1irosustatIBA
12/2007
1Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
12/2007
1TamoxifenFDA LinkGeneric
12/2007
1FI-700IBA
08/2007
1Progesterone Receptors (Progesterone Receptor)IBA
08/2007

Therapy/Procedure

6Therapeutics
04/2016 - 09/2003
5Drug Therapy (Chemotherapy)
11/2015 - 02/2006
4Oral Administration
08/2014 - 08/2007
1Castration
05/2008